Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-09-28
1998-12-15
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514675, 514693, A61K 3140, A61K 3112, A61K 3111
Patent
active
058497838
ABSTRACT:
Physically and chemically latentiated autobiotics are described. The latentiated autobiotics are useful for the treatment or prevention of any disease or condition, which results from the presence of nonself cells in a vertebrate host. Latentiated autobiotics are furthermore useful in suppressing immune rejection processes, as radiosensitizers and as anticoagulants.
REFERENCES:
patent: 4066650 (1978-01-01), Egyud
patent: 4440740 (1984-04-01), Fix et al.
Apple, M.A. and Greenberg, D.M., "Arrest of Cancer in Mice by Therapy with Normal Metabolites," Cancer Chemotherapy Reports (Part 1) 52(7):687-696 (1968).
Egyud, L.G. and Gyorgyi, A., "Cancerostatic Action of Methylglyoxal," Science, 160:1140 (1968).
Underwood, G.E. et al., "Binding of an Antiviral Agent (Kethoxal) by Various Metabolites," Proc. Soc. Exp. Biol. Med., 100:312-315 (1959).
Underwood, G.E. et al., "Glyoxal and Relatd Compounds as Potential Blood Sterilizing Agents," Proc. Soc. Exp. Biol. Med., 93:421-424 (1956).
Tiffany, B.D. et al., "Antiviral Compounds, I. Aliphatic Glyoxals, .alpha.-Hydroxyaldehydes and Related Compounds," J. Am. Chem. Soc, 79:1682-1690 (1656).
Nozawa, Y. and Fox, S.W., "Microencapsulation of Methylglyoxal and Two Derivatives," J. of Pharm. Sci, 70(4):385-386 (1981).
Thornalley, P.J., "The Glyoxalase System: New Developments Towards Functional Characterization of a Metabolic Pathway Fundamental to Biological Life," Biochem. J., 269:1-11 (1990).
Schenk, P. et al., "Studies on Sucrose-Palmitate-Stearate-Containing Vasicles Encapsulating the Cytostatic Drug Methylglyoxal-Bis-Guanyl-Hydra-zone," Pharmazie, 45:747-748 (1990).
Arndt, D. et al., "Liposomes as Carrier of Methyl-GAG," Oncology, 44:257-262 (1987).
Taylor, T.W.J. et al., "The Metallic Componds of Certain Monoximes and the Structure of the Oximes," J. Chem. Soc., pp. 2818-2819 (1926).
Jerzykowski, T. et al., "Antineoplastic Action of Methylglyoxal," Neoplasma, 17:25-35 (1970).
Schauenstein, H. et al., Aldehydes in Biological Sustems, Pion Ltd. London pp. 1-8 (1977).
Schauenstein, H. et al., "Dicarbonyl Compounds," Aldehydes in Biological Systems, Pion Ltd. London pp. 112-157 (1977).
Schauenstein, H. et al., "Schematic Survey of the most Important Aldehydes Involved in Intermediary Metabolism," Aldehydes in Biological Systems, Pion Ltd. London pp. 163-171 (1977).
Gordon, S.G., Cancer Procoagulant, in Hemostatis and Cancer (ed. L. Muszbek) CRC Press, pp. 19-31 (1987).
Ostro, M.J. and Cullis, P.R., "Use of Liposomes as Injectable-Drug Delivery Systems," Am. J. Hosp. Pharm., 46:1576-1589 (1989).
Rabjohn, J., "Selenium Dioxide Oxidation," Organic Reactions, 5:331-387 (1949).
Freedberg, W.B. et al., "Lethal Synthesis of Methylglyoxal by Escherichia Coli During Unregulated Glycerol Metabolism," J. of Bacterial., 108(1):137-144 (1971).
Barrett, P.A. et al., "Biological Activities of Some .alpha.-dithiosemicarbazones," Nature, 206:1340-1341 (1965).
Mehrishi, J.N. and Grassetti, D.R., "Sulphydryl Groups on the Surface of Intact Ehrlich Ascites Tumour Cells, Human Blood Platelets and Lymphocytes," Nature, 224:563-564 (1969).
Riley, H.L. et al., "Selenium Dioxide, a New Oxidising Agent. Part 1. Its Reaction With Aldehydes and Ketones," J. Chem. Soc. pp. 1875-1883 (1932).
Cox, E.G. et al., "The Planar Configuration of Quadricovalent Compounds of Bivalent Copper and Nickel," J. Chem. Soc., 129:129-133 (1936).
Szoka, F., Jr., "Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes)," Ann. Rev. Biophys. Bioeng., 9:467-508 (1980).
Egyud, L.G. and Szent-Gyorgyi, A., "Cell Division, SH, Ketoaldehydes, and Cancer," Proc. Acad. Sci USA, 55:388-393 (1966).
Apple, M.A. and Greenberg, D.M., "Arrest of Cancer in Mice by Therapy with Notmal Metabolites," Cancer Chem. Rep., 51:455-464 (1967).
Stein, S.M. and Berestecky, J.M., "Inhibition of Growth by Masking of Arginine Moieties in Protein at the Cell Surface," Cancer Research, 34:3112-3116 (1974).
Stein, S.M. and Berestecky, J.M., "Exposure of an Argenine-Rich Protein at Surface of Cells in S, G.sub.2, and M Phases of the Cell Cycle," J. Cell. Physiol., 85:243-249 (1975).
Egyud, L.G., "Studies on Autobiotics: Retine in Human Urine," Biochem. J., 96:19c-20c (1965).
Egyud, l.G., "Studies on Autobiotics: Chemical Nature of Retine," Proc. Natl. Acad. Sci. USA, 54(1):200-202 (1965).
Mertz, E.T., "Liposomes Capturing Increases Attention, " Biotechnology, 5:6 (1987).
Mehrishi, J.N., "Molecular Aspects of the Mammalian Cell Surface," Progress in Biophys. and Mol. Biol., 125:3-70 (1972).
Ray, M. et al., "Inhibition of Respiration of Tumor Cells by Methylglyoxal and Protection of Inhibition by Lactaldehyde," Int. J. Caner, 47:603-609 (1991).
Cell Research Corporation
Kishore Gollamudi S.
LandOfFree
Autobiotics and their use in eliminating nonself cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Autobiotics and their use in eliminating nonself cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autobiotics and their use in eliminating nonself cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1458448